The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2017
Filed:
Feb. 06, 2012
Applicants:
Brendan Curti, Portland, OR (US);
Magdalena Kovacsovics-bankowski, Portland, OR (US);
Ed Walker, Portland, OR (US);
Josh Walker, Portland, OR (US);
Andy Weinberg, Portland, OR (US);
Inventors:
Brendan Curti, Portland, OR (US);
Magdalena Kovacsovics-Bankowski, Portland, OR (US);
Ed Walker, Portland, OR (US);
Josh Walker, Portland, OR (US);
Andy Weinberg, Portland, OR (US);
Assignee:
PROVIDENCE HEALTH & SERVICES—OREGON, Renton, WA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 14/715 (2006.01); G01N 33/574 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); C07K 14/7151 (2013.01); G01N 33/56966 (2013.01); A61K 2039/505 (2013.01); A61K 2039/6031 (2013.01); C07K 2317/20 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01); C07K 2317/94 (2013.01); C07K 2319/74 (2013.01); G01N 2333/705 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7028 (2013.01);
Abstract
OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.